Reuters -- Savient Pharmaceuticals Inc's proposed gout drug Krystexxa appears effective, but serious heart complications and other safety issues are a concern, U.S. health regulators said in a memo released on Friday.
Reuters -- Savient Pharmaceuticals Inc's proposed gout drug Krystexxa appears effective, but serious heart complications and other safety issues are a concern, U.S. health regulators said in a memo released on Friday.
